Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SHE:000766)

Market Cap	22.54B +29.9%
Revenue (ttm)	1.17B -11.7%
Net Income	31.83M -45.9%
EPS	0.04 -40.8%
Shares Out	966.49M
PE Ratio	708.03
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,772,100
Average Volume	21,829,210
Open	22.78
Previous Close	23.32
Day's Range	22.78 - 23.56
52-Week Range	18.29 - 30.20
Beta	0.58
RSI	51.25
Earnings Date	Apr 22, 2026

About SHE:000766

Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products in China. Its products primarily focus on the rheumatism, digestion, cancer, and gynecology fields. The company offers traditional Chinese medicines, such as gynecological, rheumatic and bone pain, urology, detoxification, cardio-cerebral, digestive, respiratory, diabetes, and pediatric medication products, as well as anti-tumor drugs, prescription and OTC drugs, and Western medicines. The company offers ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 1,480
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000766

Financial Performance

In 2025, SHE:000766's revenue was 1.17 billion, a decrease of -11.54% compared to the previous year's 1.32 billion. Earnings were 34.29 million, a decrease of -39.25%.